Amarin has a STRONG TEAM & BOARD OF DIRECTORS--to Ensure that Vascepa Launch is done well.
Amarin"s Board of Directors have selected a Top CEO--who has brought in top talent to LAUNCH Vascepa.
I have checked all those listed in Management team as well on Board of Directors.
They are top class--you can read their BIOS.
Paul Ruff--was with Reliant from 2004-2008 .So he went thru LOVAZA launch.
From 2005-2007--the LOVAZA sales rose to 500mil.$--363mil.$ for first 9 months thru Sept.2007-- GSK bought Reliant in Nov.2012(Thankgiving date).
Reliant was a private co.--but lot of data is available as they were planning to go public.
You can find Sales estimates for 2013 by Security analysts --169 mil.$ as well as EPS.
These Security analysts are from top co.and they do their Due Diligence.